Digestive System Carcinoma — Trials

Digestive System Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

7,545 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,124
Recruiting: 1,216
Ph III recruiting: 129
Growth YoY: +12.6%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (885)

clinicaltrialsPublishedShowing 601–650 of 2,675 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06914687	Efficacy of Tirellizumab Combined With Oral, Intravenous and Abdominal Chemotherapy in Peritoneal Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma	active not recruiting	Phase 2	30	Fudan UniversityOTHER	1	Jul 28, 2026	clinicaltrials
NCT07059494	Atezolizumab and Bevacizumab in Combination With Y^90 Radioembolization in HCC for Liver Transplant	recruiting	Phase 4	40	Icahn School of Medicine at Mount SinaiOTHER	1	Jul 28, 2026